<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-23040
MEDIS EL LTD.
805 THIRD AVENUE
NEW YORK, NEW YORK 10022
(212) 935-8484
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
ORDINARY SHARES, PAR VALUE NIS 0.1 PER SHARE
(Title of each class of securities covered by this Form)
Place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(i) |X|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(1)(ii) |_|
Rule 12g-4(a)(2)(i) |X| Rule 12h-3(b)(2)(i) |X|
Rule 12g-4(a)(2)(ii) |_| Rule 12h-3(b)(2)(ii) |_|
Rule 15d-6 |_|
Approximate number of holders of record as of the certification or
notice date: 12
Pursuant to the requirements of the Securities Exchange Act of 1934
Medis El Ltd. has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
Date: June 23, 2000 By: /s/ ROBERT K. LIFTON
-------------------------------
Robert K. Lifton
Chairman of the Board
